REVITOPE ONCOLOGY
Revitope is developing a novel approach to cancer immunotherapy. Cancer patients typically have strong cytotoxic immunity against viral pathogens while lacking immunity against their tumors. Revitope’s technology redirects an exisiting viral immune response to treat cancer. Revitope’s antibody peptide epitope complex (APEC) technology selectively delivers an immunodominant viral peptide to the tumor cell, thereby activating exisiting T cells that recognize the tumor as virally infected, and kill it.
REVITOPE ONCOLOGY
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.revitope.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
8.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.revitope.com
- Host name: 152.121.199.104.bc.googleusercontent.com
- IP address: 104.199.121.152
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
